50 Recruiting Metastatic Prostate Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Metastatic Prostate Cancer
Related Conditions
Top Recruiting Metastatic Prostate Cancer Studies
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
📍 Research Site — Detroit, Michigan
View Study & Checklist ➔Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
📍 Columbia University Irving Medical Center — New York, New York
View Study & Checklist ➔Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
📍 Exelixis Clinical Site #4 — Tucson, Arizona
View Study & Checklist ➔Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
📍 Prostate Cancer Centre — Calgary, Alberta
View Study & Checklist ➔INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
📍 Cedars Sinai Medical Centre — Los Angeles, California
View Study & Checklist ➔ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Physician- and Patient-based Barriers to NGS Testing
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer
📍 St. Michael's hospital — Toronto, Ontario
View Study & Checklist ➔Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study of AZD0754 in Participants With Metastatic Prostate Cancer
📍 Research Site — Duarte, California
View Study & Checklist ➔High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
📍 Rocky Mountain Regional VA Medical Center, Aurora, CO — Aurora, Colorado
View Study & Checklist ➔Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
📍 Research Site — Fayetteville, Arkansas
View Study & Checklist ➔Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
📍 Research Site — Duarte, California
View Study & Checklist ➔Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
📍 Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
📍 Princess Margaret Cancer Center — Toronto, Ontario
View Study & Checklist ➔A Study of Tarlatamab for People With Prostate Cancer
📍 UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) — San Diego, California
View Study & Checklist ➔First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
📍 Research Site — Orlando, Florida
View Study & Checklist ➔Study of ORIC-944 in Patients With Metastatic Prostate Cancer
📍 Rocky Mountain Cancer Center — Colorado Springs, Colorado
View Study & Checklist ➔Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
📍 Rocky Mountain Cancer Center — Colorado Springs, Colorado
View Study & Checklist ➔